Coronavirus (COVID-19)
Vaccine Monitor: Uptake of Booster Shots Accelerates
Nearly a quarter of fully vaccinated adults have already received a COVID-19 booster shot, more than double the share who had done so in October, our new report reveals. It also examines support for workplace vaccine mandates and frustration with the U.S. vaccination campaign.
News Release
Latest from Kaiser Health News
Greater Than COVID
NEW VIDEOS EXPAND THE CONVERSATION: Pediatricians Answer Questions about Children and the COVID-19 Vaccines
THE CONVERSATION / LA CONVERSACIÓN expands to address information needs about the COVID-19 vaccines available to children 5 and older and the status of vaccines for younger children. Produced by KFF under its Greater Than COVID public information response, this campaign is presented with the American Academy of Pediatrics. The new videos join the expansive living video library featuring Black and Latinx health care workers answering common questions on the COVID vaccines (available in English and Spanish). YouTube/Google, Facebook, Twitter and Pinterest are supporting distribution.
Read MoreState Data and Policy Actions to Address Coronavirus
There have been over 3 million cases and 131,000 deaths due to COVID-19 in the U.S. Every state and Washington D.C. have eased or lifted at least one social distancing requirement — including 39 states that have eased or lifted stay-at-home orders.
COVID-19 Coronavirus Tracker
This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 11.8 million confirmed cases and 544,000 confirmed deaths worldwide.
COVID-19 and Related State Data
Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospitalizations, vaccinations and mental illness.
-
KFF COVID-19 Vaccine Monitor: Media and Misinformation
This report examines COVID-19 misinformation and finds that nearly eight in ten adults either believe or are unsure about at least one false statement about COVID-19 or the vaccines. It also examines the news and social media sources the public trusts for information on the virus, and the relationship between news sources and belief in misinformation.
-
Nearly 3 in 10 Parents of Children Ages 5-11 Say Their Child Will Get a Vaccine Right Away Once Able
This report tracks the public’s COVID-19 vaccine intentions, including parents’ intentions for their children ages 5-11 who may soon become eligible to get a vaccine. It also examines workers’ experiences with and views toward employer vaccine mandates.
-
Views On The U.S. Role In Global Vaccine Distribution
This report finds the public is generally supportive of U.S. distribution of vaccines internationally, though more likely to prefer the U.S. playing a major role versus a leading one, and there are partisan differences. The analysis also examines how information affects the public’s views.
-
U.S. International COVID-19 Vaccine Donations Tracker
This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies.
Rapid Home Tests for COVID-19: Issues with Availability and Access in the U.S.
In this brief, we examine the various interrelated factors that have contributed to rapid home test scarcity in the U.S. There are several interrelated factors that impact the availability of rapid home COVID-19 tests. These range from the regulatory environment to the supply chain to federal investment and messaging to affordability.
Most private insurers are no longer waiving cost-sharing for COVID-19 treatment
This analysis finds nearly three quarters of the largest health plans in each state are no longer waiving enrollees’ cost-sharing requirements for COVID-19 treatment as of August 2021. Insurers largely waived those costs early in the pandemic, before safe and effetive vaccines were available.
Five Things to Know about the Cost of COVID-19 Testing and Treatment
This brief answer key questions on affordability of COVID-19 testing and treatment for people who are uninsured and those insured through private coverage, Medicare, and Medicaid.
COVID-19 Test Prices and Payment Policy
This analysis examines list prices for COVID-19 testing at the largest hospitals in every state and finds they range widely from $20 to $850. Federal law now requires private insurers to cover COVID-19 tests at no cost to the patient and provides funding for people without health insurance.
Advancing Health Equity Requires More and Better Data
Increasing availability of high-quality comprehensive data disaggregated by race/ethnicity is a prerequisite for efforts to advance health equity, not only related to COVID-19 but in health and health care more broadly.
The Impact of the COVID-19 Pandemic on LGBT+ People’s Mental Health
The COVID-19 pandemic, which has disrupted the lives of people across the globe, has negatively impacted LGBT+ people’s mental health in disproportionate ways. In this data note, we pull together data from nationally representative surveys, adding to a small but growing evidence base on the impact of the pandemic on LGBT+ people.
Are Health Centers Facilitating Equitable Access to COVID-19 Vaccinations?
The latest data show that people of color made up 64 percent of people receiving the first dose and 61 percent of people receiving the second/final dose of the COVID-19 vaccine at community health centers.